In T-lymphoblastic leukemia cells (T-ALL), inhibiting G9a activity suppresses cellular proliferation and induces apoptosis by downregulating the expression of Bcl-2 and upregulating the expression of Bax and caspase-3 [155]. Here, EHMT2 is linked to acute lymphoblastic leukemia.